Research Volume 125 | 2017
Associations between Source-Specific Fine Particulate Matter and Emergency Department Visits for Respiratory Disease in Four U.S. Cities
Jenna R. Krall,1 James A. Mulholland,2 Armistead G. Russell,2 Sivaraman Balachandran,2,3 Andrea Winquist,4 Paige E. Tolbert,4 Lance A. Waller,1 and Stefanie Ebelt Sarnat4
PDF Version (420 KB)
Background: Short-term exposure to ambient fine particulate matter (PM2.5) concentrations has been associated with increased mortality and morbidity. Determining which sources of PM2.5 are most toxic can help guide targeted reduction of PM2.5. However, conducting multicity epidemiologic studies of sources is difficult because source-specific PM2.5 is not directly measured, and source chemical compositions can vary between cities.
Objectives: We determined how the chemical composition of primary ambient PM2.5 sources varies across cities. We estimated associations between source-specific PM2.5 and respiratory disease emergency department (ED) visits and examined between-city heterogeneity in estimated associations.
Methods: We used source apportionment to estimate daily concentrations of primary source-specific PM2.5 for four U.S. cities. For sources with similar chemical compositions between cities, we applied Poisson time-series regression models to estimate associations between source-specific PM2.5 and respiratory disease ED visits.
Results: We found that PM2.5 from biomass burning, diesel vehicle, gasoline vehicle, and dust sources was similar in chemical composition between cities, but PM2.5 from coal combustion and metal sources varied across cities. We found some evidence of positive associations of respiratory disease ED visits with biomass burning PM2.5; associations with diesel and gasoline PM2.5 were frequently imprecise or consistent with the null. We found little evidence of associations with dust PM2.5.
Conclusions: We introduced an approach for comparing the chemical compositions of PM2.5 sources across cities and conducted one of the first multicity studies of source-specific PM2.5 and ED visits. Across four U.S. cities, among the primary PM2.5 sources assessed, biomass burning PM2.5 was most strongly associated with respiratory health.
Citation: Krall JR, Mulholland JA, Russell AG, Balachandran S, Winquist A, Tolbert PE, Waller LA, Sarnat SE. 2017. Associations between source-specific fine particulate matter and emergency department visits for respiratory disease in four U.S. cities. Environ Health Perspect 125:97–103; http://dx.doi.org/10.1289/EHP271
Address correspondence to J.R. Krall, Emory University, Department of Biostatistics and Bioinformatics, Suite 369, Mailstop 1518-002-3AA, 1518 Clifton Rd., Atlanta, GA 30030 USA. Telephone: (412) 965-2012. E-mail: email@example.com
This publication is based in part upon information obtained through the Georgia Hospital Association, the Missouri Hospital Association, the Dallas–Fort Worth Hospital Council Foundation Information and Quality Services Center’s collaborative hospital data initiative, and individual hospitals. We are grateful for the support of all participating hospitals.
Research reported in this publication was supported by a Clean Air Research Center grant to Emory University and the Georgia Institute of Technology from the U.S. Environmental Protection Agency (EPA; RD834799). This publication was also made possible by a U.S. EPA STAR Grant (RD-83386601) and by grants to Emory University from the U.S. EPA (R82921301), the National Institute of Environmental Health Sciences/National Institutes of Health (NIH) (R01ES11294 and T32ES012160), and the Electric Power Research Institute (EP-P27723/C13172, EP-P4353/C2124, EP-P34975/C15892, EP-P45572/C19698, and EP-P25912/C12525).
The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the U.S. EPA. Further, the U.S. EPA does not endorse the purchase of any commercial products or services mentioned in the publication.
The authors declare they have no actual or potential competing financial interests.
Received: 3 August 2015
Revised: 2 March 2016
Accepted: 25 May 2016
Published: 17 June 2016
Note to readers with disabilities: EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact firstname.lastname@example.org. Our staff will work with you to assess and meet your accessibility needs within 3 working days.
- Supplemental Material PDF (294 KB)
Note to readers with disabilities: EHP has provided a 508-conformant table of contents summarizing the Supplemental Material for this article (see below) so readers with disabilities may determine whether they wish to access the full, nonconformant Supplemental Material. If you need assistance accessing journal content, please contact email@example.com. Our staff will work with you to assess and meet your accessibility needs within 3 working days.
Supplemental Table of Contents PDF (108 KB)
Many epidemiologic studies have reported positive associations between short-term exposure to ambient fine particulate matter (PM) air pollution, PM < 2.5 μm in aerodynamic diameter (PM2.5), and increased mortality and morbidity (Dominici et al. 2006; Samoli et al. 2013; Stafoggia et al. 2013). PM2.5, constituents of which include metal oxides, sulfate, organic carbon (OC), and elemental carbon (EC) (Bell et al. 2007), varies geographically in chemical composition depending on its natural and/or anthropogenic generating sources (Hackstadt and Peng 2014; Hopke et al. 2006). Individual PM2.5 chemical constituents vary in their associations with adverse health outcomes (Krall et al. 2013; Ostro et al. 2008; Sarnat et al. 2015). Because PM2.5 sources emit mixtures of chemical constituents, source-specific PM2.5 also varies in its associations with adverse health outcomes (Ito et al. 2006; Mar et al. 2006; Sarnat et al. 2008). Estimated associations between source-specific PM2.5 and health have varied among previous studies, which have primarily used data from one city or from a few communities (Bell et al. 2014; Mar et al. 2006; Sarnat et al. 2008). Multicity studies provide the means to fully compare estimated associations of source-specific PM2.5 across cities. Understanding which PM2.5 sources are the most toxic could help inform targeted reduction and possibly regulation of ambient PM2.5, which at the present time is regulated by total mass concentration via the U.S. National Ambient Air Quality Standards (NAAQS).
Conducting epidemiologic studies of PM2.5 sources is challenging because source-specific ambient PM2.5 cannot be directly measured and must be estimated using methods such as source apportionment models. Standard source apportionment models estimate source-specific PM2.5 separately for each ambient monitor using PM2.5 constituent concentrations. In multicity studies, PM2.5 sources estimated separately at each ambient monitor must be matched between monitors, which is difficult because PM2.5 sources can vary between cities in both chemical composition and concentration (Ito et al. 2004; Sarnat et al. 2008). For cities located far apart from each other, the chemical composition of some PM2.5 sources may vary between cities because of local differences in industry, types of vehicles, or other factors.
Previously observed city-to-city heterogeneity in PM–health associations (Samet et al. 2000; Franklin et al. 2007) may be driven by differences in population or exposure characteristics, such as susceptibility or air conditioning use, respectively, or by differences between cities in the chemical composition of source-specific PM2.5. We can eliminate some of this between-city variation by only comparing estimated health effect associations of sources whose chemical compositions do not vary substantially between cities. By restricting our analysis to sources with similar chemical composition across cities, we can better compare estimated health effect associations of the same exposures, that is to say, source-specific PM2.5, across cities.
Although most U.S. studies of source-specific PM2.5 have used data from only one or two ambient monitors (Hopke et al. 2006; Sarnat et al. 2008), a few multicommunity epidemiologic studies of source-specific PM2.5 have been conducted. Bell et al. (2014) estimated source-specific PM2.5 using data from five ambient monitors in Massachusetts and Connecticut, although the monitors were located in four contiguous counties and likely measured similar sources. Ito et al. (2013) estimated source-specific PM2.5 across 64 U.S. cities but did not quantify how similar the sources were between cities. Although these multicity studies estimated associations between source-specific PM2.5 and health, a more comprehensive evaluation of how the chemical composition of PM2.5 sources varies across cities is still needed.
We estimated associations between short-term exposure to source-specific PM2.5 and respiratory disease emergency department (ED) visits for four U.S. cities: Atlanta, Georgia; Birmingham, Alabama; St. Louis, Missouri; and Dallas, Texas. These cities, which are located in the southern and midwestern United States, likely have some PM2.5 sources that are similar in chemical composition across cities, but others may differ because of the presence of different industries, varying meteorology, or other factors. We focused on primary PM2.5 sources, such as traffic and coal combustion, which emit PM2.5 directly. Separately for each city, we estimated source-specific PM2.5 and then identified those sources with similar chemical compositions across cities. For similar sources, we estimated associations between source-specific PM2.5 and respiratory disease ED visits. In this paper, we report how source apportionment results can be compared between cities in epidemiologic studies of air pollution, and we present the first multicity U.S. study of the associations between primary source-specific PM2.5 and respiratory disease ED visits.
We obtained electronic billing data for respiratory disease ED visits for all ages at acute care hospitals in the 20-county Atlanta metropolitan area, the 7-county Birmingham metropolitan area, the 8 Missouri and 8 Illinois counties in the St. Louis metropolitan area, and the 12-county Dallas metropolitan area. Previous studies described the data collection for Atlanta (Sarnat et al. 2010) and St. Louis (Sarnat et al. 2015). Using diagnosis codes from the International Classification of Diseases, 9th Revision (ICD-9), we considered subcategories of respiratory diseases including pneumonia (ICD-9 codes 480–486), chronic obstructive pulmonary disease (COPD) (491, 492, 496), upper respiratory infection (URI) (460–465, 466.0, 477), and asthma and/or wheeze (493, 786.07). We created a combined category of daily respiratory disease ED visits by adding the number of daily ED visits for these subcategories and including additional ICD-9 codes for bronchiolitis (466.1, 466.11, 466.19). We used ED visit data in accordance with our data use agreements with the Georgia Hospital Association, the Missouri Hospital Association, the Dallas–Fort Worth Hospital Council Foundation, and selected individual hospitals. The Emory University Institutional Review Board approved this study and granted an exemption from informed consent requirements, given the minimal risk nature of the study and the infeasibility of obtaining informed consent from individual patients for > 1.8 million billing records.
We obtained concentrations for PM2.5 mass and PM2.5 constituents from one urban, ambient monitor located in each city for the following time periods: Jefferson Street in Atlanta from 1999–2009, North Birmingham in Birmingham from 2004–2010, Blair Street in St. Louis from 2001–2007, and Hinton Street in Dallas from 2006–2009.
Daily pollution data were available in Atlanta; however, data were only available approximately every third day in the remaining three cities. To ensure estimated sources more closely resembled known PM2.5 sources, our source apportionment models incorporated additional data including concentrations of gaseous pollutants and, when available, the Community Multiscale Air Quality with Tracers (CMAQ-TR) model (Baek 2009). We obtained meteorological data for each city, including temperature and relative humidity, from the National Climatic Data Center.
Source apportionment models generally assume that observed PM2.5 constituent concentrations X are formed as a linear combination of source profiles Λ, the chemical composition of each source, and daily concentrations of source-specific PM2.5 F, plus some independent error ε; that is, X = ΛF + ε. We used an ensemble approach to estimate city-specific ensemble-based source profiles (EBSPs). The EBSPs are then used in chemical mass balance with gas constraints (CMB-GC) to estimate concentrations of source-specific PM2.5, a process which is described in detail elsewhere (Balachandran et al. 2012; Lee et al. 2009).
To estimate source profiles for each city, the EBSP approach uses a weighted average of several source apportionment models. Because of the variations in available information across cities, we used a different set of source apportionment models for each city, including CMB with molecular markers (Atlanta and St. Louis), CMB-GC (Marmur et al. 2005) (all cities), the CMAQ-TR model (Atlanta, Birmingham, and St. Louis), positive matrix factorization (PMF) (Paatero and Tapper 1994) (all cities), and PMF using molecular markers (St. Louis). These source apportionment methods have been used in other studies of source-specific PM2.5 and are described elsewhere (Maier et al. 2013; Sarnat et al. 2008). By using multiple source apportionment methods in each city, we were able to leverage the advantages of each method. To account for differences in source-specific PM2.5 between summer and winter months, EBSPs were estimated separately for warm and cold seasons using data from July and January, respectively. Two months were used because these were the only months for which results were available for CMAQ and CMB with molecular markers.
Concentrations of source-specific PM2.5 were estimated separately for each city using CMB-GC, which uses gaseous pollutants to improve estimates of source-specific PM2.5 (Marmur et al. 2005). The winter EBSPs were used to estimate concentrations of source-specific PM2.5 for November through March, and the summer EBSPs were used to estimate concentrations for the remaining months. Because the same approach (CMB-GC) was used to estimate source concentrations for each city, sources with similar EBSPs were compared between cities despite incorporating different source apportionment methods. Although secondary PM2.5 sources were not the focus of this study, source profiles for secondary sources were also included in the CMB-GC.
To assess similarity among the chemical compositions of source-specific PM2.5 across cities, we compared the proportions of each PM2.5 constituent in each source using normalized root mean squared differences (nRMSDs) of the EBSPs, which were normalized by the average range (maximum–minimum) within EBSPs for each source (Marzo 2014). We also used correlations to indicate whether PM2.5 constituents in each estimated source were linearly associated. The correlations and nRMSDs were computed by comparing EBSPs for a particular source between two cities, separately for winter and summer EBSPs, and summarizing across pairwise comparisons between cities for each season using the average, minimum, and maximum values. To assess similarity between EBSPs for each source, we used a 10% cutoff in the maximum nRMSD across pairwise comparisons.
Associations with ED Visits
To estimate associations between short-term exposure to source-specific PM2.5 and respiratory disease ED visits, we applied overdispersed Poisson time-series regression models to data from each city controlling for potential confounders as in previous studies of PM2.5 and cardiorespiratory ED visits (Winquist et al. 2015). Specifically, we included indicator variables for holidays, day of the week, season, and the hospitals reporting data for each day. We controlled for meteorology using separate cubic polynomials for same-day (lag 0) maximum temperature, the mean of previous-day and 2 days before (lags 1–2) minimum temperature, and the mean of lags 0–2 dewpoint temperature. We controlled for long-term trends in ED visits using cubic splines of time with one degree of freedom per month. Last, we incorporated pairwise interaction terms between season and each of the following: maximum temperature, weekdays, and federal holidays. We estimated associations separately for each source for single-day exposures at lags 0, 1, 2, and 3. Because we did not have daily source-specific PM2.5 concentrations for Birmingham, St. Louis, and Dallas, we could not estimate exposures across multiple days. We scaled the resulting relative risks by the median of the city-specific interquartile ranges (IQR) corresponding to each source. We only estimated associations between source-specific PM2.5 and ED visits for those sources that had similar chemical compositions across cities based on the nRMSD. We compared estimated health effect associations across cities using chi-squared tests of heterogeneity (Kleinbaum et al. 1982; Rothman et al. 2008).
The estimated chemical composition of source-specific PM2.5 from source apportionment models may not correspond well to the true source chemical composition in each city. We explored an alternative approach by estimating health effect associations corresponding to individual “tracer” PM2.5 chemical constituents known to be emitted from various PM2.5 sources. Inconsistencies between estimated associations of source-specific PM2.5 and estimated associations of tracer PM2.5 constituents may indicate that estimated source-specific PM2.5 may not correspond well to known PM2.5 sources.
As a sensitivity analysis, we estimated associations separately for subcategories of respiratory diseases including pneumonia, COPD, URI, and asthma/wheeze. To determine whether our results were sensitive to the confounders included in our health effects regression models, we compared our results with those from models without product terms, without dewpoint temperature, without lag 1–2 minimum temperature, without season, without holidays, and without holidays and weekdays. To investigate possible exposure misclassification, we compared our analysis of ED visits for patients residing in all counties of the surrounding metropolitan area with analyses using only ED visits from patients residing in the county or counties closest to each city center, which contained the ambient monitoring site (DeKalb and Fulton Counties, Atlanta; Jefferson County, Birmingham; St. Louis County and St. Louis City, St. Louis; Dallas County, Dallas).
The EBSPs were derived based on the source apportionment results that could be obtained for each city. For example, some source apportionment models, such as CMB with molecular markers, require more data than we had readily available for some cities. To determine whether our results were sensitive to the varying combinations of source apportionment methods across cities, we also estimated source profiles using a standard CMB approach in each city.
Across four U.S. cities, we identified six primary PM2.5 sources including biomass burning, diesel vehicles, gasoline vehicles, dust, coal combustion, and metals, although each source was not identified in all cities. We did not identify a coal combustion source in St. Louis, nor did we identify a metals source in Atlanta and Dallas, although the remaining sources were present in all four cities. The metals source is a composite source representing industrial facilities such as steel processing (Lee et al. 2006). The estimated city- and season-specific EBSPs, which are unitless but can be interpreted as the amount (in micrograms/cubic meter) of each constituent per microgram/cubic meter of source-specific PM2.5, are displayed in Figures S1 and S2. We summarized differences in EBSPs using N pairwise comparisons between cities for each season, which yielded N correlations and N nRMSDs for each source (Table 1). For the EBSPs corresponding to biomass burning, diesel vehicles, gasoline vehicles, and dust, the maximum nRMSD across pairwise comparisons was < 10% and their correlations were also close to 1, suggesting strong similarity in these sources across cities. The EBSPs for coal combustion and metals varied between cities, with the maximum nRMSD > 10% and smaller correlations; therefore, we did not compare their estimated associations with ED visits across cities (Table 1; see also Figures S1 and S2).
For each city, we estimated concentrations of source-specific PM2.5 for 3,624 days in Atlanta, 808 days in Birmingham, 728 days in St. Louis, and 332 days in Dallas. Table 2 shows the average concentrations and standard deviations (micrograms/cubic meter) of source-specific PM2.5 for each city. For primary PM2.5 sources, we found that the greatest concentrations corresponded to biomass burning. Correlations between concentrations of source-specific PM2.5 and PM2.5 mass were generally small to moderate (see Table S1).
Associations with ED Visits
The average number of daily ED visits for combined respiratory diseases was 361 (standard deviation = 129) for Atlanta, 59 (27) for Birmingham, 281 (81) for St. Louis, and 455 (159) for Dallas (see Table S2). In each city, the majority of daily respiratory disease ED visits were for URI.
Figure 1 shows the estimated relative risks and 95% confidence intervals (CIs) for an interquartile range (IQR) increase in PM2.5 mass and PM2.5 from biomass burning, diesel vehicles, gasoline vehicles, and dust for single-day lags 0 to 3. We did not compare associations across cities for PM2.5 from coal combustion or metals because their EBSPs varied substantially between cities (Table 1). For PM2.5 mass, associations with respiratory disease ED visits were frequently positive and statistically significant across cities, although the lag of greatest association varied between cities. For lag 2, the relative risk of respiratory disease ED visits associated with an IQR increase in PM2.5 mass was 1.006 (95% CI: 1.001, 1.010) for Atlanta, 1.008 (95% CI: 1.002, 1.014) for Birmingham, 1.008 (95% CI: 1.002, 1.014) for St. Louis, and 1.003 (95% CI: 0.993, 1.014) for Dallas. Associations for PM2.5 from biomass burning were positive and were frequently greater in magnitude than for other sources. The relative risk associated with an IQR increase in lag 2 PM2.5 from biomass burning was 1.006 (95% CI: 1.003, 1.010) for Atlanta, 1.008 (95% CI: 0.996, 1.019) for Birmingham, 1.007 (95% CI: 0.999, 1.016) for St. Louis, and 1.001 (95% CI: 0.989, 1.013) for Dallas.
Figure 1 – Estimated relative risks of respiratory disease emergency department (ED) visits for interquartile range (IQR) increases in fine particulate matter (PM2.5) mass and source-specific PM2.5 using single-day exposure lags 0 to 3 for Atlanta, Georgia; Birmingham, Alabama; St. Louis, Missouri; and Dallas, Texas.
For PM2.5 from diesel vehicles and gasoline vehicles, estimated associations were inconsistent across cities and lags with many near-null associations or associations with large standard errors. Across lags, the estimated associations in St. Louis were more positive for gasoline vehicles than for diesel vehicles. Associations with diesel and gasoline vehicles in Dallas had larger confidence intervals than other sources, which may be explained by the relatively low temporal variability of PM2.5 from these sources. Across cities and exposure lags, we did not find evidence that PM2.5 from dust was associated with respiratory disease ED visits. Using chi-squared tests of heterogeneity, we did not find evidence that estimated associations differed across cities for any PM2.5 source at any lag.
We selected tracer constituents to correspond to our identified sources based on Sarnat et al. (2008), including potassium for PM2.5 from biomass burning, EC for PM2.5 from diesel vehicles, zinc for PM2.5 from gasoline vehicles, and silicon for PM2.5 from dust. We also examined OC, which is emitted by biomass burning, diesel vehicles, and gasoline vehicles, but is not associated with dust PM2.5. Although none of these constituents is generated solely by the specified source categories, they can be used to help interpret the source-specific results. Tables S3–S6 summarize the data for PM2.5 constituent tracers, including correlations between source-specific PM2.5 and tracer constituents (Table S6).
For each city, we estimated associations between tracer constituents and respiratory disease ED visits to assess consistency with the associations observed for source-specific PM2.5 (Figure 2). For biomass burning PM2.5, the observed patterns of associations across cities and lags were similar to the patterns observed for potassium and OC, which are tracers for PM2.5 from biomass burning. Although we did not observe positive associations for diesel vehicles in Atlanta and Birmingham, we found some positive associations between EC and ED visits in these cities. EC, though generally a better tracer for diesel PM2.5 than for biomass burning PM2.5, was moderately correlated with biomass burning PM2.5 in these cities (0.42 and 0.47, respectively). There was little evidence of association for zinc, a tracer for gasoline PM2.5, or silicon, a tracer for dust PM2.5, consistent with the source-specific results.
Figure 2 – Estimated relative risks of respiratory disease emergency department (ED) visits for interquartile range increases in selected tracer fine particulate matter (PM2.5) constituents using single-day exposure lags 0 to 3 for Atlanta, Georgia; Birmingham, Alabama; St. Louis, Missouri; and Dallas, Texas. The following tracers were selected: potassium (K) for biomass burning PM2.5, elemental carbon (EC) for diesel PM2.5, zinc (Zn) for gasoline PM2.5, silicon (Si) for dust PM2.5, and organic carbon (OC) for both mobile and burning PM2.5.
We found that estimated health effect associations for subcategories of respiratory diseases had wider confidence intervals than those for combined respiratory diseases because there were fewer daily counts for each subcategory (see Figures S3–S6). We found some evidence of associations between PM2.5 from biomass burning and URI in all cities except Dallas, although the lag corresponding to the largest associations varied between cities.
We found that results were mostly consistent across models with varying confounder control, although our estimated relative risks were frequently greater in magnitude in models without control for weekdays and holidays (results not shown). We did not find that restricting our analysis to patients residing in the counties closest to each city center and containing the PM2.5 monitoring sites substantially changed our results (results not shown). We also did not find that our estimated health effect associations substantially changed when we used a standard CMB approach rather than the EBSP approach for estimating source-specific PM2.5.
In a multicity U.S. study that examined the associations between primary source-specific PM2.5 and respiratory disease ED visits, we found some evidence of positive associations across cities for PM2.5 from biomass burning. The inconsistency in estimated associations for diesel and gasoline vehicles across cities might be driven by the spatial heterogeneity of mobile PM2.5 and the placement of monitors relative to roadways in each city. In addition, the large standard errors for PM2.5 from diesel and gasoline vehicles in Dallas are likely driven by the relatively low temporal variation in these sources (Table 2). Associations with PM2.5 from dust were smaller in magnitude and were frequently consistent with the null across cities. The lags where the associations were largest in magnitude varied between cities, which might be driven by between-city differences in hospital use. Between-city differences in estimated health effect associations of source-specific PM2.5 could also be driven by differences in their respective populations, including air conditioning use and susceptibility (Bell et al. 2009; Ostro et al. 2008), or by differential exposure error.
Previous studies have estimated associations between respiratory morbidity and source-specific PM2.5. Sarnat et al. (2008) did not find evidence of positive associations between respiratory disease ED visits and PM2.5 from gasoline vehicles, diesel vehicles, wood smoke, or soil in Atlanta, but they used same-day exposure and had a shorter time frame than was available in the present study. Andersen et al. (2007) found that PM < 10 μm (PM10) from biomass burning was associated with increased respiratory hospital admissions in Copenhagen, Denmark. Gass et al. (2015) found positive associations between pediatric asthma ED visits in Atlanta and gasoline and diesel PM2.5; these associations were larger in magnitude than those found for biomass burning PM2.5. Other studies have found evidence of associations between respiratory hospitalizations and traffic PM2.5 (Ito et al. 2013) and road dust PM2.5 (Bell et al. 2014), although these studies did not identify biomass burning as a source of PM2.5.
We observed positive associations between biomass burning PM2.5 and respiratory ED visits, which corresponded well to observed associations for OC and potassium. Although OC is emitted by biomass burning PM2.5, OC is also associated with mobile PM2.5 including PM2.5 from gasoline and diesel vehicles and secondary formation from gaseous emissions. OC consists of many organic compounds that could be used to differentiate the sources of OC, such as levoglucosan as an indicator of biomass burning; however, we did not have daily speciated OC data available for the entirety of this study. Speciated OC data were used in developing the source profiles used in our source apportionment approach (Balachandran et al. 2013), and other studies have used speciated OC data (Zheng et al. 2007). In general, estimated associations for source-specific PM2.5 had more uncertainty than estimated associations for PM2.5 constituents, likely because source-specific PM2.5 is estimated and is not directly measured.
We found that EBSPs for PM2.5 from biomass burning, diesel vehicles, gasoline vehicles, and dust were similar across cities, whereas greater differences existed for EBSPs for PM2.5 from coal combustion and metals (Table 1; see also Figures S1 and S2). A previous study of the same urban ambient monitors in Atlanta and Birmingham also found the same PM2.5 sources to have similar chemical compositions between monitors (Lee et al. 2008). Correlations and nRMSDs are simple tools that can be applied to compare source profiles across cities; however, future work could develop statistical models that provide a more rigorous framework for comparing estimated PM2.5 sources across cities.
Although source apportionment models have been primarily developed for data from a single ambient monitor, two previous studies developed source apportionment models for multiple ambient monitors (Jun and Park 2013; Thurston et al. 2011). These models may not be appropriate for multicity epidemiologic studies because they fix source profiles across monitors. For example, in our study, we found that source profiles (EBSPs) for PM2.5 from coal combustion and metals varied across cities.
In source apportionment studies, we commonly estimate source-specific PM2.5 but do not directly model the known PM2.5 sources in each city (e.g., factories). Therefore, some sources estimated using source apportionment might not exactly correspond to existing PM2.5 sources. Other methods, such as dispersion modeling, can be used to estimate source-specific PM2.5 across a community. However, these methods are generally not applied to time-series data and require information that may not be available for all communities. In contrast, source apportionment models can be readily applied to time series of PM2.5 constituent concentrations, which are measured in most urban areas at ambient monitors. Source apportionment studies can also be used to identify groups of PM2.5 chemical constituents that are most harmful to human health to help focus future epidemiologic studies on relevant PM2.5 sources.
In this analysis, we did not propagate uncertainty from estimating source-specific PM2.5 into our estimated health associations. The EBSP approach provides uncertainties associated with estimating source-specific PM2.5, and future work could determine how to best incorporate these uncertainties in health effects regression models. Bayesian ensemble-based source apportionment (Balachandran et al. 2013; Gass et al. 2015) and fully Bayesian models (Nikolov et al. 2007) could also be used to propagate the uncertainty from estimating source-specific PM2.5.
The approach we developed to compare the chemical composition of source-specific PM2.5 across cities can be applied to examine city-to-city heterogeneity in source-specific PM2.5 and how it might explain city-to-city heterogeneity in health effects of PM2.5 mass. In our study, chi-squared tests of heterogeneity did not reveal that estimated associations for source-specific PM2.5 varied across cities; however, longer time series may be needed to fully examine between-city differences. We were unable to examine city-to-city heterogeneity in estimated associations across cities using multilevel models because we were limited to data from four U.S. cities. Although national-level data on ED visits and source-specific PM2.5 are not readily available, future work incorporating such data from selected additional cities will be relevant to addressing this objective.
Our study of source-specific PM2.5 across four U.S. cities was limited by the amount of available data. We had data from one ambient monitor in each city, which did not allow us to examine spatiotemporal heterogeneity in PM2.5 mass or PM2.5 constituents across each city. In addition, we only had concentrations of PM2.5 chemical constituents to estimate source-specific PM2.5 every third day in Birmingham, St. Louis, and Dallas, which limited our ability to fit distributed lag models or models using multiday exposures. Lall et al. (2011) found stronger associations for cardiorespiratory hospital admissions using multiday lagged exposures; therefore, our estimated associations for single-day exposures may be smaller in magnitude than those associated with multiday exposures.
PM2.5 constituents have only been collected nationally since 2000 (U.S. EPA 2009), and future work may be able to utilize longer time series to resolve observed differences in estimated associations between cities. Dallas had a shorter time series of data than the other cities investigated herein, with only 332 days of source-specific PM2.5 spanning 2006–2009, which led to broad confidence intervals for the estimated associations. For Atlanta and Birmingham, where longer time series were available, we observed somewhat more consistent results across lags (Figures 1 and 2). Longer time series in each city would also improve our ability to estimate associations between source-specific PM2.5 and ED visits by age group.
To our knowledge, this is the first multicity study of primary source–specific PM2.5 and ED visits. Larger, national-level studies are necessary to inform future NAAQS; however, we have provided a framework for comparing estimated source-specific PM2.5 between cities.
In this multicity study of the associations between primary source–specific PM2.5 and ED visits for respiratory diseases, we found some evidence of positive associations across all cities with PM2.5 from biomass burning. Associations with PM2.5 from diesel and gasoline vehicle sources were less consistent across cities and lags, which could be driven by the spatial heterogeneity of the sources. There was little evidence of association with PM2.5 from dust. We found that PM2.5 from coal combustion and metal sources varied in chemical composition across cities, which presents challenges for comparing estimated health effect associations between cities. Our approach provides an analytic framework for multicity studies of PM2.5 sources to determine those sources most associated with adverse health outcomes and to help inform targeted reduction of ambient PM2.5.
Andersen ZJ, Wahlin P, Raaschou-Nielsen O, Scheike T, Loft S. 2007. Ambient particle source apportionment and daily hospital admissions among children and elderly in Copenhagen. J Expo Sci Environ Epidemiol 17:625–636.
Baek J. 2009. Improving Aerosol Simulations: Assessing and Improving Emissions and Secondary Organic Aerosol Formation in Air Quality Modeling [PhD Dissertation]. Atlanta, GA:Georgia Institute of Technology.
Bell ML, Dominici F, Ebisu K, Zeger SL, Samet JM. 2007. Spatial and temporal variation in PM2.5 chemical composition in the United States for health effects studies. Environ Health Perspect 115:989–995, doi: 10.1289/ehp.9621.
Bell ML, Ebisu K, Leaderer BP, Gent JF, Lee HJ, Koutrakis P, et al. 2014. Associations of PM2.5 constituents and sources with hospital admissions: analysis of four counties in Connecticut and Massachusetts (USA) for persons ≥ 65 years of age. Environ Health Perspect 122:138–144, doi: 10.1289/ehp.1306656.
Gass K, Balachandran S, Chang HH, Russell AG, Strickland MJ. 2015. Ensemble-based source apportionment of fine particulate matter and emergency department visits for pediatric asthma. Am J Epidemiol 181:504–512.
Hopke PK, Ito K, Mar T, Christensen WF, Eatough DJ, Henry RC, et al. 2006. PM source apportionment and health effects: 1. Intercomparison of source apportionment results. J Expo Sci Environ Epidemiol 16:275–286.
Ito K, Christensen WF, Eatough DJ, Henry RC, Kim E, Laden F, et al. 2006. PM source apportionment and health effects: 2. An investigation of intermethod variability in associations between source-apportioned fine particle mass and daily mortality in Washington, DC. J Expo Sci Environ Epidemiol 16:300–310.
Ito K, Ross Z, Zhou J, Nádas A, Lippmann M, Thurston GD. 2013. NPACT Study 3. Time-series analysis of mortality, hospitalizations, and ambient PM2.5 and its components. In: National Particle Component Toxicity (NPACT) Initiative: Integrated Epidemiologic and Toxicologic Studies of the Health Effects of Particulate Matter Components. Lippmann M, Chen LC, Gordon T, Ito K, Thurston GD, eds. Research Report 177. Health Effects Institute, Boston, MA, 95–125.
Krall JR, Anderson GB, Dominici F, Bell ML, Peng RD. 2013. Short-term exposure to particulate matter constituents and mortality in a national study of U.S. urban communities. Environ Health Perspect 121:1148–1153, doi: 10.1289/ehp.1206185.
Lall R, Ito K, Thurston GD. 2011. Distributed lag analyses of daily hospital admissions and source-apportioned fine particle air pollution. Environ Health Perspect 119:455–460, doi: 10.1289/ehp.1002638.
Lee JH, Hopke PK, Turner JR. 2006. Source identification of airborne PM2.5 at the St. Louis-Midwest Supersite. J Geophys Res Atmos 111:D10, doi: 10.1029/2005JD006329.
Lee S, Liu W, Wang Y, Russell AG, Edgerton ES. 2008. Source apportionment of PM2.5: comparing PMF and CMB results for four ambient monitoring sites in the southeastern United States. Atmos Environ 42:4126–4137.
Maier ML, Balachandran S, Sarnat SE, Turner JR, Mulholland JA, Russell AG. 2013. Application of an ensemble-trained source apportionment approach at a site impacted by multiple point sources. Environ Sci Technol 47:3743–3751.
Mar TF, Ito K, Koenig JQ, Larson TV, Eatough DJ, Henry RC, et al. 2006. PM source apportionment and health effects. 3. Investigation of inter-method variations in associations between estimated source contributions of PM2.5 and daily mortality in Phoenix, AZ. J Expo Sci Environ Epidemiol 16:311–320.
Ostro BD, Feng WY, Broadwin R, Malig BJ, Green RS, Lipsett MJ. 2008. The impact of components of fine particulate matter on cardiovascular mortality in susceptible subpopulations. Occup Environ Med 65(11):750–756.
Samet JM, Zeger SL, Dominici F, Curriero F, Coursac I, Dockery DW, et al. 2000. The National Morbidity, Mortality, and Air Pollution Study, part II: morbidity and mortality from air pollution in the United States. Res Rep Health Eff Inst 94(pt 2):5–70.
Samoli E, Stafoggia M, Rodopoulou S, Ostro B, Declercq C, Alessandrini E, et al. 2013. Associations between fine and coarse particles and mortality in Mediterranean cities: results from the MED-PARTICLES Project. Environ Health Perspect 121:932–938, doi: 10.1289/ehp.1206124.
Sarnat JA, Marmur A, Klein M, Kim E, Russell AG, Sarnat SE, et al. 2008. Fine particle sources and cardiorespiratory morbidity: an application of chemical mass balance and factor analytical source-apportionment methods. Environ Health Perspect 116:459–466, doi: 10.1289/ehp.10873.
Sarnat SE, Klein M, Sarnat JA, Flanders WD, Waller LA, Mulholland JA, et al. 2010. An examination of exposure measurement error from air pollutant spatial variability in time-series studies. J Expo Sci Environ Epidemiol 20:135–146.
Sarnat SE, Winquist A, Schauer JJ, Turner JR, Sarnat JA. 2015. Fine particulate matter components and emergency department visits for cardiovascular and respiratory diseases in the St. Louis, Missouri–Illinois, metropolitan area. Environ Health Perspect 123:437–444, doi: 10.1289/ehp.1307776.
Stafoggia M, Samoli E, Alessandrini A, Cadum E, Ostro B, Berti G, et al. 2013. Short-term associations between fine and coarse particulate matter and hospitalizations in southern Europe: results from the MED-PARTICLES project. Environ Health Perspect 121:1026–1033, doi: 10.1289/ehp.1206151.
Winquist A, Schauer JJ, Turner JR, Klein M, Sarnat SE. 2015. Impact of ambient fine particulate matter carbon measurement methods on observed associations with acute cardiorespiratory morbidity. J Expo Sci Environ Epidemiol 25:215–221.
Zheng M, Cass GR, Ke L, Wang F, Schauer JJ, Edgerton ES, et al. 2007. Source apportionment of daily fine particulate matter at Jefferson Street, Atlanta, GA, during summer and winter. J Air Waste Manag Assoc 57:228–242.
EHP is pleased to announce that “Prenatal Fluoride Exposure and Cognitive Outcomes in Children at 4 and 6–12 Years of Age in Mexico,” published in EHP on 19 September 2017, has been selected by the Children’s Environmental Health Network (CEHN) as its December 2017 Article of the Month. (more…)
EHP has revised the descriptions of the manuscript types it accepts for potential publication. Please consult the updated Instructions to Authors before submitting a new manuscript to EHP.